-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $39

Benzinga·08/14/2026 10:47:15
Listen to the news
Raymond James analyst Christopher Raymond initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Outperform rating and announces Price Target of $39.